Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Loss and dysregulation of Th17 cells during HIV infection.

Bixler SL, Mattapallil JJ.

Clin Dev Immunol. 2013;2013:852418. doi: 10.1155/2013/852418. Epub 2013 May 23. Review.

2.

Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.

Chege D, Sheth PM, Kain T, Kim CJ, Kovacs C, Loutfy M, Halpenny R, Kandel G, Chun TW, Ostrowski M, Kaul R; Toronto Mucosal Immunology Group.

AIDS. 2011 Mar 27;25(6):741-9. doi: 10.1097/QAD.0b013e328344cefb.

PMID:
21378536
3.

Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection.

Hofer U, Speck RF.

Semin Immunopathol. 2009 Jul;31(2):257-66. doi: 10.1007/s00281-009-0158-3. Epub 2009 May 30.

PMID:
19484240
4.

Th17 cells, HIV and the gut mucosal barrier.

Dandekar S, George MD, Bäumler AJ.

Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3. Review.

PMID:
20543596
5.

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.

Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, Jongrakthaitae S, Akapirat S, Fletscher JL, Kroon E, Dewar R, Trichavaroj R, Chomchey N, Douek DC, O Connell RJ, Ngauy V, Robb ML, Phanuphak P, Michael NL, Excler JL, Kim JH, de Souza MS, Ananworanich J; RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups.

PLoS Pathog. 2014 Dec 11;10(12):e1004543. doi: 10.1371/journal.ppat.1004543. eCollection 2014 Dec.

6.

Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21.

Pallikkuth S, Micci L, Ende ZS, Iriele RI, Cervasi B, Lawson B, McGary CS, Rogers KA, Else JG, Silvestri G, Easley K, Estes JD, Villinger F, Pahwa S, Paiardini M.

PLoS Pathog. 2013;9(7):e1003471. doi: 10.1371/journal.ppat.1003471. Epub 2013 Jul 4.

7.

The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.

Chevalier MF, Petitjean G, Dunyach-Rémy C, Didier C, Girard PM, Manea ME, Campa P, Meyer L, Rouzioux C, Lavigne JP, Barré-Sinoussi F, Scott-Algara D, Weiss L.

PLoS Pathog. 2013;9(6):e1003453. doi: 10.1371/journal.ppat.1003453. Epub 2013 Jun 20.

8.

Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation.

Kim CJ, McKinnon LR, Kovacs C, Kandel G, Huibner S, Chege D, Shahabi K, Benko E, Loutfy M, Ostrowski M, Kaul R.

J Immunol. 2013 Sep 1;191(5):2164-73. doi: 10.4049/jimmunol.1300829. Epub 2013 Jul 26.

9.

Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.

Page EE, Greathead L, Metcalf R, Clark SA, Hart M, Fuchs D, Pantelidis P, Gotch F, Pozniak A, Nelson M, Boasso A, Gazzard B, Kelleher P.

J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):227-35. doi: 10.1097/QAI.0000000000000294.

PMID:
25314246
10.

Th17, gut, and HIV: therapeutic implications.

Hunt PW.

Curr Opin HIV AIDS. 2010 Mar;5(2):189-93. doi: 10.1097/COH.0b013e32833647d9. Review.

11.

Th17 lineage commitment and HIV-1 pathogenesis.

Ancuta P, Monteiro P, Sekaly RP.

Curr Opin HIV AIDS. 2010 Mar;5(2):158-65. doi: 10.1097/COH.0b013e3283364733. Review.

PMID:
20543594
12.

Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands.

Alvarez Y, Tuen M, Shen G, Nawaz F, Arthos J, Wolff MJ, Poles MA, Hioe CE.

J Virol. 2013 Oct;87(19):10843-54. doi: 10.1128/JVI.01838-13. Epub 2013 Jul 31.

13.

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.

DaFonseca S, Niessl J, Pouvreau S, Wacleche VS, Gosselin A, Cleret-Buhot A, Bernard N, Tremblay C, Jenabian MA, Routy JP, Ancuta P.

Retrovirology. 2015 Apr 30;12:38. doi: 10.1186/s12977-015-0164-6.

14.

Th17 cell dynamics in HIV infection.

Klatt NR, Brenchley JM.

Curr Opin HIV AIDS. 2010 Mar;5(2):135-40. doi: 10.1097/COH.0b013e3283364846. Review.

15.

CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.

Ciccone EJ, Greenwald JH, Lee PI, Biancotto A, Read SW, Yao MA, Hodge JN, Thompson WL, Kovacs SB, Chairez CL, Migueles SA, Kovacs JA, Margolis LB, Sereti I.

J Virol. 2011 Jun;85(12):5880-8. doi: 10.1128/JVI.02643-10. Epub 2011 Apr 6.

16.

HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli.

Dillon SM, Manuzak JA, Leone AK, Lee EJ, Rogers LM, McCarter MD, Wilson CC.

J Immunol. 2012 Jul 15;189(2):885-96. doi: 10.4049/jimmunol.1200681. Epub 2012 Jun 11.

17.

Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

Márquez M, Fernández Gutiérrez del Álamo C, Girón-González JA.

World J Gastroenterol. 2016 Jan 28;22(4):1433-48. doi: 10.3748/wjg.v22.i4.1433. Review.

18.

Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.

Cao W, Mehraj V, Vyboh K, Li T, Routy JP.

AIDS Rev. 2015 Jul-Sep;17(3):135-46. Review.

PMID:
26450802
19.

Microbial translocation in the pathogenesis of HIV infection and AIDS.

Marchetti G, Tincati C, Silvestri G.

Clin Microbiol Rev. 2013 Jan;26(1):2-18. doi: 10.1128/CMR.00050-12. Review.

20.

A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis.

Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, Mujib S, Benko E, Kovacs C, Shin LY, Grin A, Kandel G, Loutfy M, Ostrowski M, Gommerman JL, Kaushic C, Kaul R.

Mucosal Immunol. 2012 Nov;5(6):670-80. doi: 10.1038/mi.2012.72. Epub 2012 Aug 1.

PMID:
22854709

Supplemental Content

Support Center